Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19

Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutral...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sun Bean, Kim, Jimin, Huh, Kyungmin, Choi, Won Suk, Kim, Yae-Jean, Joo, Eun-Jeong, Kim, Youn Jeong, Yoon, Young Kyung, Heo, Jung Yeon, Seo, Yu Bin, Jeong, Su Jin, Yu, Su-Yeon, Peck, Kyong Ran, Choi, Miyoung, Yeom, Joon Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258293/
https://www.ncbi.nlm.nih.gov/pubmed/34216134
http://dx.doi.org/10.3947/ic.2021.0304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258293/
https://www.ncbi.nlm.nih.gov/pubmed/34216134
http://dx.doi.org/10.3947/ic.2021.0304

Ejemplares similares